An episode of paroxysmal atrial fibrillation with unexpected ending Case report

Main Article Content

Maria Różańska
Martyna Zaleska
Piotr Suwalski
Dariusz A. Kosior
Olga Możeńska

Abstract

We present a case of 52-year-old male with restrictive cardiomyopathy as well as with history of paroxysmal atrial fibrillation in whom detailed diagnostic process led to suspicion of light-chain deposition disease as a reason for left ventricular hypertrophy.

Downloads

Download data is not yet available.

Article Details

How to Cite
Różańska , M., Zaleska , M., Suwalski , P., Kosior , D. A., & Możeńska , O. (2018). An episode of paroxysmal atrial fibrillation with unexpected ending . Cardiology in Practice, 12(3-4), 3-5. Retrieved from https://journalsmededu.pl/index.php/kwp/article/view/1204
Section
On the border of cardiology

References

1. Pozzi C, D’Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003; 42(6): 1154-1163.
2. Buxbaum JN, Chuba JV, Hellman GC et al. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis: clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990; 112(6): 455-464.
3. Fabbian F, Stabellini N, Sartori S et al. Light chain deposition disease presenting as paroxysmal atrial fibrillation: a case report. J Med Case Rep 2007; 1: 187.
4. Koopman P, Van Dorpe J, Maes B, Dujardin K. Light chain deposition disease as a rare cause of restrictive cardiomyopathy. Acta Cardiol 2009; 64(6): 821-824.
5. Chugh SS, Blackshear JL, Shen WK et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001; 37(2): 371-378.
6. Benjamin EJ, Wolf PA, D’Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98(10): 946-952.
7. Williams LK, Frenneaux MP, Steeds RP. Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur J Echocardiogr 2009; 10(8): iii9-14.
8. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336(4): 267-276.
9. Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol 2010; 55(17): 1769-1779.
10. Pozzi C, Locatelli F. The patient with insidious chronic renal failure and the patient with the nephrotic syndrome – two manifestations of a protean and not so rare disease. Nephrol Dial Transplant 1996; 11(9): 1876-1880.